All News

Wal-Mart intends to contract with local hospitals and other organizations to open as many as 400 in-store health clinics over the next two to three years.

77% of American voters support Congress' passing a bill to give the FDA the authority to regulate tobacco products.

NCPA and the VGM Group, a member service organization for home medical equipment (HME) providers, have announced an alliance that will help NCPA members enter the HME market or advance their HME business.

The Medicare Part D prescription drug plan market changed little with the second open-enrollment period, despite changes in plan benefits and formularies.

According to an analysis of 2006 prescription drug claim histories by PBM Express Scripts, 23% of seniors who fell into the Medicare Part D donut hole coverage gap could have avoided it altogether by using more generics.

Eligible members will receive an annual medication review as well as additional MTM services from trained pharmacists to help them achieve safe and effective results from their medications while controlling costs.

DEA claims that AmerisourceBergen did not maintain effective controls against diversion of controlled substances, specifically hydrocodone, to four Internet pharmacies from Jan. 1, 2006, through Jan. 31, 2007.

PharmaFab is a major contract manufacturer and distributor of more than 100 different Rx and OTC products, including cough and cold products, ulcer treatments, and postpartum hemorrhage products.

British pharmaceutical giant AstraZeneca announced it is acquiring Gaithersburg, Md.-based MedImmune for $15.6 billion.

"We strongly feel that not only should the FDA do guidance prior to approving, but also require clinical evidence."

San Francisco supervisors recently passed the first ban in the nation on plastic bags. The bill applies to large grocers and all pharmacies in the city and bans the use of petroleum-based bags.

CVS unveiled added benefits to customers of its ExtraCare program, including the introduction of Extra Bucks Now.

America?s pharmaceutical research companies, YMCA of the USA, and Easter Seals have joined forces to help uninsured children access health care.

Medicine Shoppe pharmacies led the retail chain segment, receiving the highest ratings in all factors driving customer satisfaction.

The study is the first in a phase of solutions that IRI will be releasing on health and wellness opportunities.

Rite Aid expects to close its acquisition of the Brooks and Eckerd drugstore chains by the end of May

The Medicare Modernization Act requires HHS to develop uniform standards for the electronic transmission of prescriptions.

Cardiovascular disease and diabetes are expected to be the therapeutic areas most impacted by the coverage gap

The FDA has approved zoledronic acid (Reclast, Novartis) injection as the first new treatment in nearly a decade for patients with the bone condition Paget's disease

CDHP participants were less likely than traditional health plan enrollees to change behavior and take advantage of cost-saving generic drugs, instead opting to curtail brand-medication use.

Support Coordinators are oncology nurses and other trained professionals available by phone to help patients work their way through the complexities of drug access and reimbursement.

Debilitating pain-affecting millions of Americans-was often alleviated by traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors. But the appeal of these once-popular drugs is declining due to safety concerns.

On April 30, 1939, the World's Fair opened in New York City. The theme for the fair was "building the world of tomorrow," and pharmacists were ready to do just that.

Following guidelines issued by the American Pharmacists Association in February, the federal government has also issued guidelines on the disposal of medications.

CMS has issued a final rule establishing a competitive bidding program for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) furnished to Medicare beneficiaries under Part B.

Two high-quality reports in the New England Journal of Medicine confirming the risk of valvulopathy with the use of pergolide (Permax, Valiant) have led the FDA to remove the drug from the U.S. market. Two generic forms of the drug, made by Teva and Par Pharmaceuticals, will also be withdrawn.

Trimethobenzamide-containing suppositories are the next product in line to hit the FDA's chopping block as part of the agency's ongoing effort to ensure that all marketed drugs have been officially approved. The rectally administered treatment of nausea and vomiting has been available under the brand names Tigan, Tebamide, Trimazide, Trimethobenz, and T-Gen.

The FDA plans to conduct a study to evaluate the quantity and quality of consumer medication information.